|This Slide: #6 of 100|
Slide #6. ICON — Aptiv Solutions
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the previously announced acquisition of Aptiv Solutions.
Icon is a clinical research organization, which provides outsourced development services to the pharmaceutical, biotechnology and medical device industries. Co. focuses on development, management and analysis of programs that support all stages of the clinical development process - from compound selection to Phase I-IV clinical studies. Co. is engaged in providing services to its customers, which include clinical trial management, consulting, contract staffing and laboratory services. Co. has capability to conduct clinical trials in therapeutic areas and has the operational flexibility to provide development services on a stand-alone basis or as part of an integrated full service solution.
Open the ICLR Page at The Online Investor »
Buy (2.62 out of 4)
(ranked lower than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite